SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SynDevRx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2799
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SynDevRx Inc (SDX) is a drug development company that develops treatments for cancer and metabolic dysfunction. The company offers lead compound SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active novel small molecule fumagillol derivative in vivo. Its services include clinical trial design and management, process development, chemistry, manufacturing and controls, toxicology, pharmacology, and regulatory affairs. SDX offers treatments for obesity, type 2 diabetes, rheumatoid arthritis, and fatty liver disease. It conducts clinical trials for developing new therapies to improve future treatment for various cancer types and conditions associated with metabolic dysfunction. The company partners with clinical oncologists, researchers, professors and medical professional to develop drugs. SDX is headquartered in Cambridge, Massachusetts, the US.

SynDevRx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SynDevRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SynDevRx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SynDevRx Raises USD0.5 Million in Venture Financing 10
SynDevRx Raises USD0.5 Million in Venture Financing 11
SynDevRx Raises Additional USD1 Million in Venture Financing 12
SynDevRx Raises Additional USD1.1 Million in Venture Financing 13
SynDevRx Raises Additional USD9 Million in Venture Financing 14
SynDevRx Raises US$2.2 Million In Venture Financing 15
SynDevRx Raises Additional USD1.6 Million in Financing 16
SynDevRx Raises Funds in Venture Financing 17
SynDevRx Inc – Key Competitors 18
SynDevRx Inc – Key Employees 19
SynDevRx Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SynDevRx Inc, Pharmaceuticals & Healthcare, Key Facts 2
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SynDevRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SynDevRx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SynDevRx Raises USD0.5 Million in Venture Financing 10
SynDevRx Raises USD0.5 Million in Venture Financing 11
SynDevRx Raises Additional USD1 Million in Venture Financing 12
SynDevRx Raises Additional USD1.1 Million in Venture Financing 13
SynDevRx Raises Additional USD9 Million in Venture Financing 14
SynDevRx Raises US$2.2 Million In Venture Financing 15
SynDevRx Raises Additional USD1.6 Million in Financing 16
SynDevRx Raises Funds in Venture Financing 17
SynDevRx Inc, Key Competitors 18
SynDevRx Inc, Key Employees 19

List of Figures
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SynDevRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SynDevRx Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nakheel:企業の戦略・SWOT・財務情報
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dyas BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Dyas BV (Dyas) a subsidiary of SHV Holdings N.V., is an oil and gas company that offers oil exploration and production programs. The company offers products which include crude oil and natural gas. It operates projects which include Buzzard, Broom, Elgin and Franklin; Bergen, Middelie, Zuid …
  • EnerSys (ENS):企業の財務・戦略的SWOT分析
    EnerSys (ENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Keepmoat Ltd:企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Spectrum Brands Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spectrum Brands Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spectrum Brands Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • GW Pharmaceuticals Plc (GWP):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Schweitzer-Mauduit International Inc (SWM):企業の財務・戦略的SWOT分析
    Schweitzer-Mauduit International Inc (SWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Duke Energy Corporation:発電所・企業SWOT分析
    Duke Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • National Power Corp:企業の戦略的SWOT分析
    National Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gevo Inc (GEVO):企業の財務・戦略的SWOT分析
    Summary Gevo Inc (Gevo) is a renewable chemicals and advanced biofuels company that offers renewable chemicals and biofuels. The company’s products include carbon cycle products, low carbon renewable jet fuels, renewable gasoline, isobutanol blendstocks, ingredient products, animal feed and proteins …
  • AXO Science SAS:企業の製品パイプライン分析2018
    Summary AXO Science SAS (AXO) is a developer of high output and multi-parametric analysis solutions for characterizing biological samples. The company offers solutions such as blood genotyping, allergy diagnosis, cancer diagnosis, pathogens detection, customized assays, sperm tracker, microarray spo …
  • AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析
    AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Weatherford International Plc (WFT):石油・ガス:M&Aディール及び事業提携情報
    Summary Weatherford International Plc (Weatherford) is an oilfield service provider. The company offers equipment and services utilized in the drilling, evaluation, completion, production and intervention of oil and natural gas wells. Its product line includes artificial lift systems, completion sys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆